(Q35014206)

5 August 2017

Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects (English)

1 reference

5 August 2017

Yeong Shin Lee

1

1 reference

5 August 2017

Soo Hyun Kim

series ordinal

2

1 reference

5 August 2017

Jung Ah Cho

series ordinal

3

1 reference

5 August 2017

Chul Woo Kim

series ordinal

4

1 reference

5 August 2017

1 May 2011

1 reference

Experimental and Molecular Medicine

5 August 2017

1 reference

5 August 2017

43

1 reference

5 August 2017

5

1 reference

5 August 2017

281-290

1 reference

https://scigraph.springernature.com/pub.10.3858/emm.2011.43.5.029

5 August 2017

0 references

cites work

Improving vaccines by targeting antigens to dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Review: cancer immunotherapy by exosome-based vaccines

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Exosomes: a new delivery system for tumor antigens in cancer immunotherapy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Tumor-derived exosomes: a new source of tumor rejection antigens

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Modulation of gene expression by the MHC class II transactivator

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Immunoregulatory properties of mast cell-derived exosomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Exosomes: composition, biogenesis and function

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Intestinal epithelial cells secrete exosome-like vesicles

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Exosome: from internal vesicle of the multivesicular body to intercellular signaling device

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

B lymphocytes secrete antigen-presenting vesicles

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

T helper cells in cytotoxic T lymphocyte development: Analysis of the cellular basis for deficient T helper cell function in the L3T4-independent T helper cell pathway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3104250

Malignant effusions and immunogenic tumour-derived exosomes

8 July 2018

1 reference

https://api.crossref.org/works/10.3858%2FEMM.2011.43.5.029

TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3858%2FEMM.2011.43.5.029

Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3858%2FEMM.2011.43.5.029

In vitro induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes from patients with locally advanced breast cancer by tumor antigen-pulsed autologous dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3858%2FEMM.2011.43.5.029

Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3858%2FEMM.2011.43.5.029

Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3858%2FEMM.2011.43.5.029

Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21464590

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21464590

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21464590

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3858/EMM.2011.43.5.029

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference